Zobrazeno 1 - 5
of 5
pro vyhledávání: '"G Liceaga Cundin"'
Autor:
MT Artola Urain, G Liceaga Cundin, M Umerez Igartua, O Valbuena Pascual, JJ Ferreiro Martinez, P Carmona Oyaga, I Fernandez Gonzalez, MP Bachiller Cacho, J Barral Juez, A Asensio Bermejo
Publikováno v:
European Journal of Hospital Pharmacy. 21:A136.2-A137
Background When an unrelated donor is used for an allogeneic hematopoietic stem cell transplant (AlloHSCT) highly immunosuppressive treatment is needed during the early post-transplant period as prophylaxis against acute graft versus host disease (aG
Autor:
L Leunda Eizmendi, A Algaba Las Peñas, Mauleon Echeverria, I Aguirre Zubia, L Lombera Saez, P Carmona Oyaga, E Pagés Romero, MJ Gayan Lera, G Liceaga Cundin, K Andueza Granados
Publikováno v:
European Journal of Hospital Pharmacy. 21:A78.1-A78
Background Inhaled antibiotics are increasingly used in patients with non-cystic fibrosis bronchiectasis as off-label treatment, without quantifiable effectiveness. Patients’perspective is an important part of healthcare quality. Due to internal pr
Autor:
G Lopez Arzoz, MP Bachiller Cacho, G Liceaga Cundin, MI Fernandez Gonzalez, M.B. Irastorza Larburu, I Aguirre Zubia, O Valbuena Pascual, J Belzunegui Otaño, O. Maiz Alonso, MA Aranguren Redondo
Publikováno v:
European Journal of Hospital Pharmacy. 20:A163.1-A163
Background Drug dosage modifications are a common clinical practise regarding Tumor Necrosis Factor (TNF) blockers, using posologies not specified on the authorised product information summary. This practise has a significant financial impact on the
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jeffrey K. Aronson
Building on the success of the 14 previous editions, this remarkable reference has been extensively reorganized and expanded and now comprises almost 1,500 individual drug articles providing the most complete coverage of adverse reactions and interac